n-dodecane has been researched along with ursodeoxycholic acid in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Andreev, V; Belonovskaya, E; Bergler, S; Büchele, B; Buckert, D; Buko, V; Diesinger, T; Dvorsky, R; Günes, C; Haehner, T; Kirko, S; Kuchenbauer, F; Kumar, M; Lautwein, A; Lukivskaya, O; Müller-Enoch, D; Naruta, E; Renz, C; Schneider, E; Simmet, T; Wirth, T | 1 |
1 other study(ies) available for n-dodecane and ursodeoxycholic acid
Article | Year |
---|---|
Drug targeting CYP2E1 for the treatment of early-stage alcoholic steatohepatitis.
Topics: Alkanes; Animals; Cytochrome P-450 CYP2E1; Cytochrome P-450 CYP2E1 Inhibitors; Fatty Liver, Alcoholic; Female; Hep G2 Cells; Humans; Lipoproteins, VLDL; Liver; Oxidative Stress; Rats; Rats, Wistar; Reactive Oxygen Species; Severity of Illness Index; Triglycerides; Ursodeoxycholic Acid | 2020 |